Eylea 2 MG/0.05 ML vial 0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSGZ0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,283
Award facts
- Contract value 100% obligated
- $1,282.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,282.62 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for EYLEA 2 mg/0.05 ml vial (0.05 ml). The award, issued on December 5, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of December 29, 2025, and utilizes no set-aside designation. DMS Pharmaceutical Group Inc. is performing the work at its Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V program represents part of a broader $30.3 billion Department of Defense pharmaceutical acquisition strategy designed to support recurring medical supply needs across military healthcare facilities worldwide. As a prime vendor contractor, DMS Pharmaceutical Group supplies a comprehensive portfolio of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FSGZ0?
SPE2DR26FSGZ0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FSGZ0 worth?
The government has obligated $1,283 on SPE2DR26FSGZ0.
Is contract SPE2DR26FSGZ0 an order under another contract?
Yes. SPE2DR26FSGZ0 is a delivery order under SPE2DR25D9305, an indefinite delivery contract.
Was contract SPE2DR26FSGZ0 competed?
The extent of competition for SPE2DR26FSGZ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award